What actually moved in pediatrics this quarter
A hand-verified sample of 62 sources across 30+ journals and institutional sources — RSV/measles immunization, neonatal AI, pediatric asthma biologics, autism genetics, T1D technology, congenital heart disease, screen time & youth mental health, and pediatric obesity pharmacotherapy — every DOI checked against the source text before inclusion. This is what your production monthly subscription would deliver automatically.
Where the volume is, this quarter
Share of the 62-source sample, by clinical axis
Top journals in this sample
Maternal RSV vaccine + infant nirsevimab: sequencing now under RCT scrutiny
An 8-site NIH/NIAID phase 4 interim analysis (Pediatrics, June 2026) is the first to randomize mother-infant pairs across all four maternal-vaccine / nirsevimab-timing combinations — directly informing how you sequence RSV prevention in your own newborn panel this season.
US measles cases have passed 2,300 in 2026 — highest since 1991
AAP Red Book surveillance (updated Jul 30, 2026) and WHO/UNICEF's July WUENIC release both confirm the same pattern: falling kindergarten MMR coverage (92.7%) plus stalled global second-dose coverage (77%) are driving sustained outbreaks, ~70% of US cases in children/teens.
Full Source Matrix
Search or filter — every row links to the original source
| Title | Journal | Date | Domain | Design |
|---|
PEDIA-PULSE — the monthly pediatric research subscription
Delivered on the 1st of each month: a refreshed dashboard exactly like this one, scaled to a full systematic literature pull (typically 300-600+ new records/month), plus a 1-page PDF executive summary you can read in the time it takes to drink your coffee. Built and maintained by TransitionConsulting's research-intelligence practice.